Ephrayim Ent. Co., Ltd.

1. Super magical fried eggs and fried fish, they are salty without salt.
2. Can be cooked without water or oil.
3. Without any chemical coating, even if no oil is added, it will not stick to the pot or blacken the pot.
4. 360-degree cyclone circulation heating, heating time is twice as fast as that of ordinary traditional pots. It takes one hour to stew chicken soup in an ordinary pot, but only 30 minutes in a palua pot.
5. Palua is formed in one piece, without adding a thick bottom, and conducts heat evenly and quickly.
6. After the soup boils, it can be kept warm for three to four hours (cover the lid).
7. Maintain the original taste and nutrition of food, and completely lock in the delicious taste and nutrients of the ingredients without losing them.
Water-free and oil-free cooking method: Healthy pot (no oil is required for frying vegetables, frying steaks, fish fillets, chicken chops, and pork chops), making food more natural, fresher, sweeter, and healthier.

Essense Co., Ltd.

EssenseAI Co., Ltd., a subsidiary of Kimforest Enterprise Group, focuses on metabolomics, proteomics, genomics, gut microbiome, and AI-driven data analytics. Driven by the core vision of “AI from science to health”, EssenseAI is dedicated to building a Multiomics AI Platform for scientific services and health management, aiming to become a leading force in multiomics AI in the Asia-Pacific region.

The company provides a wide range of testing and analytical services, including whole-genome screening, sub-health metabolomics testing, gut microbiome profiling, cancer early detection, and environmental toxin analysis, all supported by professional AI-based interpretation.

EssenseAI has also been accredited with ISO/IEC 17025 laboratory certification by the Taiwan Accreditation Foundation (TAF), ensuring service quality and international standards of precision and reliability.

EUCARE Co.,Ltd.

Eucare Launches the New “Boodion Telemedicine Platform”
Eucare has officially launched the brand-new “Boodion Telemedicine Platform,” developed with the vision of integrating technology and healthcare services. In line with the Ministry of Health and Welfare (MOHW) and the National Health Insurance Administration (NHIA)’s digital transformation initiatives. The platform empowers clinics to modernize their operations, enhance healthcare accessibility, and provide patients with convenient, comprehensive telemedicine services.
Building on the success of the first-generation Eucare App—developed in collaboration with the Ministry of Health and Welfare (MOHW) and the Overseas Community Affairs Council (OCAC) during the COVID-19 pandemic—Eucare partnered with more than 20 major hospitals, 200 clinics, and 2,000 community pharmacies to deliver diverse healthcare services. The app reached over one million registered users, enabled over 150,000 consultations, and completed nearly 50,000 home medication deliveries, helping patients overcome barriers to medical access and prescription fulfillment.
Following the pandemic, Eucare has continued to advance telemedicine innovation. Since 2023, the company has worked with LINE Taiwan and clinic system providers to launch the new “Boodion Telemedicine Platform,” officially introduced in June last year.
By integrating LINE Official Accounts with clinic Hospital Information Systems (HIS), the platform streamlines the entire telemedicine experience—covering online registration, virtual NHI card check-in, online payment, video consultations, and e-prescription services. Physicians can conduct teleconsultations directly through the HIS interface, record medical notes, track patients’ physiological data or lab results, issue prescriptions, and complete subsequent NHI claim submissions in one seamless workflow.

EVER FORTUNE.AI CO., LTD.

EVER FORTUNE.AI, established in June 2018, has been committing to the innovation of medical big data and artificial intelligence, focusing on the applications of intelligent healthcare and precision medicine. Our vision is to become a leader in digital healthcare, aiming to improve the prevention, diagnosis, and treatment of diseases.
Since the establishment in 2018, EVER FORTUNE.AI has won 3 silver medals in world-class AI competitions and have been awarded the Taiwan National Innovation Award for 4 consecutive years. We have obtained 13 US FDA clearances, 16 Taiwan FDA clearances, 4 Vietnam medical device approvals, 5 Thailand medical device approvals as well as 28 patents worldwide.
Leveraging medical big data analysis, AI-assisted diagnostics, and cloud-based biomedical platforms, EFAI provides innovative AI-driven healthcare solutions across hospitals, pharmaceutical companies, medical aesthetics, biotechnology, and health management.
Everfortune.AI is ambitiously expanding from Taiwan to global.
We aggressively obtain more regulatory approvals from countries around the world.
By partnering with leading international companies, we expanding cross-domain network.
We become a digital healthcare leader through innovative digital technology and new business model.

Ever Supreme Bio Technology Co.,Ltd.

Ever Supreme has advanced research and developing capability in cell gene manufacturing processes of both stem cells and immune cells drugs.

EverBot Technology Co., Ltd.

The healthcare industry is under increasing pressure. In Taiwan, enrollment in five key medical specialty schools has dropped sharply. According to data from the World Health Organization (WHO), there will be a global shortage of 18 million healthcare workers by 2030, including 9 million nurses and midwives. In 2024, the average turnover rate for nurses in Taiwan’s medical centers reached 10.7%, with emergency room nurses experiencing a 9.7% turnover rate.

Taiwan’s rapidly aging population has further exacerbated the shortage of nursing staff. Nurses face repetitive and high-stress tasks, leading to burnout and declining care quality. The lack of intelligent support systems reduces efficiency and increases errors.

Currently, most medical robots focus solely on logistics, lacking semantic understanding and real-time interaction capabilities, making them inadequate for real clinical needs. EverBot generative AI medical robot is designed to fill this gap.

In the first phase, it integrates generative AI, large language models, and speech recognition technologies to provide functions such as patient navigation, health education consultations, meal ordering, remote ward rounds, and the delivery of items and instruments.

Evergreen30 Healthcare Clinic

Excelsius Medical

Excelsius Medical – Aikesha Medical Instruments
Aikesha is the only ophthalmic medical instrument brand in the world independently developed and manufactured in Taiwan. Certified with ISO 13485 and CE, it is dedicated to providing stable and effective surgical experiences for ophthalmologists and patients worldwide.

MICRON M7 Excimer Refractive Laser
Specifically designed for ophthalmic treatment needs, it integrates auto-focus technology with robotic arm control to automate surgical procedures, reduce human error, and enhance surgical efficiency, visual stability, and operational benefits.

FEMTON F1 Femtosecond Laser
A next-generation ophthalmic device featuring SectorScan minimally invasive 3D cutting technology, requiring only a 2–4 mm incision. It offers low discomfort and rapid post-operative recovery. This single platform enables surgeons to perform a wide range of procedures, including both refractive and cataract surgeries, at a more accessible cost, fulfilling the goal of comprehensive vision care for patients.

ExoOne Bio. Co., Ltd.